P Lemež
P Lemež publishes mostly in Hematology, Molecular Biology and Public Health, Environmental and Occupational Health, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Retinoids in leukemia and cellular processes.
- World rank
- #5,076,161 of 7,710,434 ranked researchers
- Rank in Czechia
- #17,646 of 39,303
- Works
- 63
- Citations
- 965
- Citations per work
- 15.3
What does P Lemež research?
P Lemež's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3758.4%
- Medicine3758.4%
- Everything else1929.9%
- Life Sciences711.7%
- 1Hematology28% of their works
- 2Molecular Biology12% of their works
- 3Public Health, Environmental and Occupational Health12% of their works
- 4Oncology7% of their works
- 5Genetics7% of their works
- 6Epidemiology5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Retinoids in leukemia and cellular processes
- Hematopoietic Stem Cell Transplantation
- Cancer Treatment and Pharmacology
- Blood disorders and treatments
- Chemotherapy-induced cardiotoxicity and mitigation
- Chronic Lymphocytic Leukemia Research
Which keywords describe P Lemež's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Acute Lymphoblastic Leukemia, Childhood Cancer, Acute Promyelocytic Leukemia and Retinoic Acid.
- Neutropenia
- Genetic Mutations
- Chronic Lymphocytic Leukemia
- Taxanes
- Graft-versus-Host Disease
- Retinoic Acid
- Childhood Cancer
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Acute Lymphoblastic Leukemia
- Acute Promyelocytic Leukemia
- Bone Marrow Niche
- Chemotherapy-Induced Peripheral Neuropathy
- Anthracyclines
- Doxorubicin
- Genomic Aberrations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors463 topics
- Hematopoietic Stem Cells383 topics
- AML281 topic
- Acute Myeloid Leukemia281 topic
- Acute Lymphoblastic Leukemia141 topic
- Childhood Cancer141 topic
- Acute Promyelocytic Leukemia111 topic
- Retinoic Acid111 topic
- Bone Marrow Niche61 topic
- Graft-versus-Host Disease61 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Taxanes51 topic
- Anthracyclines41 topic
- Chronic Lymphocytic Leukemia41 topic
- Doxorubicin41 topic
- Genetic Mutations41 topic
- Genomic Aberrations41 topic
- Neutropenia41 topic
Where does P Lemež work?
P Lemež's main affiliation in the publication record is Hospital Jihlava, Czechia.
How many publications and citations does P Lemež have?
OpenAlex counts 63 works and 965 citations for P Lemež, an h-index of 12, ranking #5,076,161 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about P Lemež. Posts are plain text and can be reported.